Central Nervous System Lymphoma — Trials

Central Nervous System Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

214 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 81
Recruiting: 54
Ph III recruiting: 5
Growth YoY: —
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 26.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (15)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05651178	Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma Patients	active not recruiting	Early Phase 1	10	Hrain Biotechnology Co., Ltd.INDUSTRY	1	Jun 4, 2026	clinicaltrials
NCT03684980	LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma	active not recruiting	Early Phase 1	58	Memorial Sloan Kettering Cancer CenterOTHER	1	Apr 15, 2026